Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Meeting the mental health needs of people with multiple sclerosis: a qualitative study of patients and professionals.
Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.
Post-translational regulation of inflammasomes.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
Increased incidence of rheumatoid arthritis in multiple sclerosis: A nationwide cohort study.
Traumatic brain injury: a risk factor for neurodegenerative diseases.
Design of TRUST, a non-interventional, multicenter, 3-year prospective study investigating an integrated patient management approach in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
Development of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case report.
Microbiomic and Posttranslational Modifications as Preludes to Autoimmune Diseases.
Cumulative evidence for MS as a neural network disconnection syndrome consistent with cognitive impairment mechanisms and the confounding role of fatigue and depression-outlook from the Fourth Nordic MS symposium.
The association between functional HLA-G 14 bp insertion/deletion and +3142 C>G polymorphisms and susceptibility to multiple sclerosis.
Scattering the spotlight on microparticles.
Regional disparities in botulinum toxin A (BoNT-A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap.
Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder.
Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices.
Extracranial Head and Neck Schwannomas: Our Experience.
Erratum to: 'Purkinje cell injury, structural plasticity and fusion in patients with Friedreich's ataxia'.
A multi-time-point modality-agnostic patch-based method for lesion filling in multiple sclerosis.
HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.
Anti-thyroid antibodies and thyroid function in neuromyelitis optica spectrum disorders.
Multiple sclerosis: Immune reconstitution effective for MS.
Exacerbation of demyelinating syndrome after exposure to wireless modem with public hotspot.
Quantitative analysis of multiple sclerosis patients' preferences for drug treatment: a best-worst scaling study.
Difference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups.
The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6.
Pages
« first
‹ previous
…
816
817
818
819
820
821
822
823
824
…
next ›
last »